Bcr-abl Inhibitor structure

Bcr-abl Inhibitor

TL;DR: Bcr-abl Inhibitor (CAS 778270-11-4) is a chemical compound with molecular formula C18H13F3N4O2 and molecular weight 374.10 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.

3-[6-[4-(trifluoromethoxy)anilino]pyrimidin-4-yl]benzamide

Also Known As: Bcr-abl Inhibitor, Bcr-abl, 3-(6-((4-(Trifluoromethoxy)phenyl)amino)pyrimidin-4-yl)benzamide, nchembio760-comp2, Bcr-abl inhibitor GNF-2

CAS: 778270-11-4
Molecular Formula C18H13F3N4O2
Molecular Weight 374.10 g/mol
LogP 3.8847
Topological Polar Surface Area 90.13 Ų
Hydrogen Bond Donors 2
Hydrogen Bond Acceptors 5
Rotatable Bonds 5
Exact Mass 374.09906
Heavy Atoms 27
Complexity 959.3206

Chemical Identifiers

CAS Number 778270-11-4
SMILES C1=CC(=CC(=C1)C(=O)N)C2=CC(=NC=N2)NC3=CC=C(C=C3)OC(F)(F)F

Product Overview

Bcr-abl Inhibitor (CAS 778270-11-4), with molecular formula C18H13F3N4O2 and molecular weight 374.10 g/mol. IUPAC: 3-[6-[4-(trifluoromethoxy)anilino]pyrimidin-4-yl]benzamide.

🧪
Safety Data Sheet (MSDS / SDS) View the Laboratory Chemical Safety Summary (LCSS) on PubChem — includes GHS classifications, hazard statements, first aid measures, and handling precautions.
View MSDS →

Chemical Property Profile of Bcr-abl Inhibitor

XLogP
3.8847
TPSA (Topological Polar Surface Area)
90.13
Hydrogen Bond Donors
2
Hydrogen Bond Acceptors
5
Rotatable Bonds
5
Heavy Atoms
27
Complexity
959.3206
Exact Mass
374.09906
Monoisotopic Mass
374.09906
Data Source: Chemical property values are referenced from PubChem, the world's largest open chemistry database maintained by the National Center for Biotechnology Information (NCBI), U.S. National Library of Medicine.

Property Insights of Bcr-abl Inhibitor

The XLogP value of 3.8847 indicates that Bcr-abl Inhibitor is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 90.13 Ų falls within the moderate polarity range, balancing permeability and solubility for Bcr-abl Inhibitor. Following Lipinski's Rule of Five, Bcr-abl Inhibitor has 2 hydrogen bond donor(s) and 5 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.

Frequently Asked Questions

What is the typical lead time for this product?
Lead time typically ranges from 3-7 business days for in-stock items. For larger quantities or custom orders, please contact us for specific lead times.
Can you provide samples for testing?
Yes, we offer sample quantities for quality testing. Please submit an inquiry with your requirements and we will arrange samples accordingly.
What documentation do you provide with the product?
We provide COA (Certificate of Analysis), MSDS (Material Safety Data Sheet), and technical data sheets with each shipment.
Do you ship internationally?
Yes, we ship to most countries worldwide. Shipping costs and delivery times vary by location. Please contact us for specific shipping information.

Frequently Asked Questions

What is the CAS number of Bcr-abl Inhibitor?

The CAS number of Bcr-abl Inhibitor is 778270-11-4.

What is the molecular formula of Bcr-abl Inhibitor?

The molecular formula of Bcr-abl Inhibitor is C18H13F3N4O2.

What is the molecular weight of Bcr-abl Inhibitor?

The molecular weight of Bcr-abl Inhibitor is 374.10 g/mol.

Where can I buy Bcr-abl Inhibitor?

You can request a quote for Bcr-abl Inhibitor directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.

Does KEHONG BIO offer custom synthesis for Bcr-abl Inhibitor?

Yes, KEHONG BIO provides custom synthesis services for Bcr-abl Inhibitor and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.

🤖 科弘生物 AI 助手 ×
您好!我是 科弘生物 AI 助手。可以问我产品搜索、询价、样品或技术问题。如何帮助您?